|
Showing 1 - 3 of
3 matches in All Departments
This, the first of two volumes on personalized medicine in lung
cancer, touches on the core issues related to the understanding of
lung cancer-statistics and epidemiology of lung cancer-along with
the incidence of lung cancer in non-smokers. A major focus of this
volume is the state of current therapies against lung
cancer-immune, targeted therapies against EGFR TKIs, KRAS, ALK,
angiogenesis; the associated challenges, especially resistance
mechanisms; and recent progress in targeted drug development based
on metal chemistry. Chapters are written by some of the leading
experts in the field, who provide a better understanding of lung
cancer, the factors that make it lethal, and current research
focused on developing personalized treatment plans. With a unique
mix of topics, this volume summarizes the current
state-of-knowledge on lung cancer and the available therapies.
This, the first of two volumes on personalized medicine in lung
cancer, touches on the core issues related to the understanding of
lung cancer-statistics and epidemiology of lung cancer-along with
the incidence of lung cancer in non-smokers. A major focus of this
volume is the state of current therapies against lung
cancer-immune, targeted therapies against EGFR TKIs, KRAS, ALK,
angiogenesis; the associated challenges, especially resistance
mechanisms; and recent progress in targeted drug development based
on metal chemistry. Chapters are written by some of the leading
experts in the field, who provide a better understanding of lung
cancer, the factors that make it lethal, and current research
focused on developing personalized treatment plans. With a unique
mix of topics, this volume summarizes the current
state-of-knowledge on lung cancer and the available therapies.
|
You may like...
Ab Wheel
R209
R149
Discovery Miles 1 490
|